Technology

Genprex

$3.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+4.53%) Today
-$0.02 (-0.51%) As of 11:19 AM UTC after-hours

Why Robinhood?

You can buy or sell Genprex and other stocks, options, and ETFs commission-free!

About GNPX

Genprex, Inc. Common Stock, also called Genprex, is a clinical-stage gene therapy company focused on developing potentially life-changing technologies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies options for large patient populations with cancer and diabetes who currently have limited treatment options. The firm works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company's lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (NSCLC). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX. The listed name for GNPX is Genprex, Inc. Common Stock.

CEO
J. Rodney Varner
Employees
8
Headquarters
Austin, Texas
Founded
2009
Market Cap
174.17M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.35M
High Today
$3.95
Low Today
$3.65
Open Price
$3.75
Volume
1.16M
52 Week High
$7.03
52 Week Low
$1.09

Collections

GNPX Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 30, After Hours

You May Also Like

NVRO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure